Skip to main content

Bimekizumab



General

Pronunciation

(BYE me KIZ ue mab)

Indications

Use: Labeled Indications

Note: Not approved in the United States.

Plaque psoriasis, moderate to severe: Treatment of moderate to severe plaque psoriasi...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×